Magic mushroom compound tested for OCD relief
NCT ID NCT05546658
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 20 times
Summary
This early-phase study tests whether psilocybin, the active ingredient in magic mushrooms, can safely help reduce symptoms of obsessive-compulsive disorder (OCD). Thirty-five adults with OCD who have not responded well to standard treatments will receive psilocybin in a controlled setting. Researchers will measure changes in OCD severity, anxiety, depression, and quality of life to see if this approach is worth studying further.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSESSIVE-COMPULSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins University School of Medicine
Baltimore, Maryland, 21224, United States
Conditions
Explore the condition pages connected to this study.